Immune-mediated cancer treatments (IMCTs) use the body’s immune system to fight cancer and are increasingly used across many cancer types.

While these treatments can be highly effective, they can also bring complex decisions and side effects that may need to be recognised early.

Our research explores how IMCTs are explained, understood, and discussed in healthcare settings, with a focus on improving how information is communicated.

We aim to improve communication between patients and clinicians, support informed treatment decisions, and promote the early recognition of treatment side effects. 

By bringing together researchers, clinicians, and patients, we aim to develop practical approaches that improve the safety, experience, and equity of IMCT care. 

We welcome collaboration with clinicians, researchers, charities, industry partners, and community organisations interested in improving communication and care in immune-mediated cancer treatment.

On this website, you can find out more about our team, current projects, how to get involved, collaboration opportunities, and how to contact us.